Sakowitz Oliver W, Raabe Andreas, Vucak Dejan, Kiening Karl L, Unterberg Andreas W
Department of Neurosurgery, University of Heidelberg, Heidelberg, Germany.
Neurosurgery. 2006 Jan;58(1):137-45; discussion 137-45. doi: 10.1227/01.neu.0000194532.47239.7c.
To assess the status quo of clinical management in patients with ruptured intracranial aneurysms in Germany. In addition to preferences in vascular treatment (i.e., surgical versus endovascular), the choice of diagnostics and treatment options in the pre- and postprocedural phase is emphasized.
A standardized questionnaire was used in a postal survey. Participants were representatives of neurosurgical departments in Germany (n = 130, total number of departments). Comparisons between groups of respondents were tested using chi statistics (Fisher's exact test, two-sided).
The overall response rate was 77% (n = 100). Preoperative assessment is standard by computed tomography and conventional angiography. Currently, endovascular treatment options are available in 71% of all responding centers. On the basis of self estimates it is projected that 63% of all ruptured aneurysms are treated surgically, whereas 37% are treated endovascularly. For anterior circulation aneurysms, a significantly higher number of respondents commit to routine or frequent use of surgical techniques compared with endovascular treatment options (93 versus 52%, P < or = 0.05). In contrast, for posterior circulation aneurysms, endovascular treatment is preferred (24 versus 94%, P < or = 0.05). Acute posthemorrhagic hydrocephalus is treated by external ventricular drainage routinely (97%). Doppler sonography, monitoring of cerebral perfusion pressure, and electrophysiology are used by a significant number of respondents. Specific treatment of subarachnoid hemorrhage (SAH) patients includes calcium antagonists (70%), glucocorticosteroids (35%), and hemorheologic agents (30%).
In Germany, aneurysmal subarachnoid hemorrhage remains a disease in which standardization of clinical management is highest in preoperative diagnostics, intensive care unit monitoring, and postoperative treatment. With respect to currently published guidelines for subarachnoid hemorrhage treatment, compliance is moderate. Preferred treatment for anterior circulation aneurysms is predominantly surgical, whereas endovascular treatment options are preferentially used in aneurysms of the posterior circulation. This survey serves as a basis to analyze future developments in the management of subarachnoid hemorrhage more effectively and as an aid in finding a consensus in treatment both nationally and internationally.
评估德国颅内动脉瘤破裂患者的临床管理现状。除了血管治疗方面的偏好(即手术治疗与血管内治疗)外,还强调了术前和术后阶段诊断和治疗方案的选择。
在一项邮寄调查中使用标准化问卷。参与者为德国神经外科科室的代表(共130个科室,n = 130)。使用卡方统计(Fisher精确检验,双侧)对受访者群体之间进行比较。
总体回复率为77%(n = 100)。术前评估的标准方法是计算机断层扫描和传统血管造影。目前,71%的所有回复中心都有血管内治疗方案。根据自我估计,预计所有破裂动脉瘤中有63%接受手术治疗,而37%接受血管内治疗。对于前循环动脉瘤,与血管内治疗方案相比,选择常规或频繁使用手术技术的受访者数量显著更多(93%对52%,P≤0.05)。相比之下,对于后循环动脉瘤,更倾向于血管内治疗(24%对94%,P≤0.05)。急性出血后脑积水通常通过脑室外引流治疗(97%)。大量受访者使用多普勒超声、脑灌注压监测和电生理检查。蛛网膜下腔出血(SAH)患者的具体治疗包括使用钙拮抗剂(70%)、糖皮质激素(35%)和血液流变学药物(30%)。
在德国,动脉瘤性蛛网膜下腔出血仍然是一种临床管理在术前诊断、重症监护病房监测和术后治疗方面标准化程度最高的疾病。就目前公布的蛛网膜下腔出血治疗指南而言,依从性一般。前循环动脉瘤的首选治疗方法主要是手术,而后循环动脉瘤则优先使用血管内治疗方案。这项调查为更有效地分析蛛网膜下腔出血管理的未来发展提供了基础,并有助于在国内和国际上达成治疗共识。